| Filed | Form | Description | |
|---|---|---|---|
| 4/14/25 | DEF 14A | DEF 14A | → |
| 4/15/24 | DEF 14A | DEF 14A | → |
| 4/17/23 | DEF 14A | DEF 14A | → |
| 4/8/22 | DEF 14A | DEF 14A | → |
| 3/21/22 | PRE 14A | PRE 14A | → |
| 4/30/21 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/5/26 | 4 | 4 | → |
| 1/5/26 | 4 | 4 | → |
| 11/20/25 | 4 | OWNERSHIP DOCUMENT | → |
| 11/20/25 | 3 | OWNERSHIP DOCUMENT | → |
| 11/18/25 | 4 | 4 | → |
| 10/8/25 | 4 | OWNERSHIP DOCUMENT | → |
| ↓ | |||
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).